Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL-6.

[1]  T. Hawley,et al.  Comparative analysis of retroviral vector expression in mouse embryonal carcinoma cells. , 1989, Plasmid.

[2]  C. Uyttenhove,et al.  Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Glasebrook,et al.  Decline in growth and antibody production of established hybridomas and transfectomas with addition of interleukin 6 , 1989, European journal of immunology.

[4]  E. Harlow,et al.  Antibodies: A Laboratory Manual , 1988 .

[5]  L. Aarden,et al.  Functional discrimination between interleukin 6 and interleukin 1 , 1988, European journal of immunology.

[6]  K. Rajewsky,et al.  Monoclonal antibodies against murine cell surface antigens: anti-H-2, anti-Ia and anti-T cell antibodies. , 1978, Current topics in microbiology and immunology.

[7]  A. Karu,et al.  The influence of murine macrophage-conditioned medium on cloning efficiency, antibody synthesis, and growth rate of hybridomas. , 1985, Journal of immunological methods.

[8]  W. Fiers,et al.  B cell growth modulating and differentiating activity of recombinant human 26‐kd protein (BSF‐2, HuIFN‐beta 2, HPGF). , 1987, The EMBO journal.

[9]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[10]  R. Lemieux,et al.  Role of the macrophage-derived hybridoma growth factor in the in vitro and in vivo proliferation of newly formed B cell hybridomas. , 1987, Journal of immunology.

[11]  W. Long,et al.  Enhancing the establishment efficiency of hybridoma cells. Use of irradiated human diploid fibroblast feeder layers. , 1986, Journal of immunological methods.

[12]  R. Hawley,et al.  Suppression of programmed death and G1 arrest in B‐cell hybridomas by interleukin‐6 is not accompanied by altered expression of immediate early response genes , 1990, Journal of cellular physiology.

[13]  A. Kimchi,et al.  Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 , 1991, Nature.

[14]  F. Melchers,et al.  The antibody repertoire of hybrid cell lines obtained by fusion of X63-AG8 myeloma cells with mitogen-activated B-cell blasts. , 1978, Current topics in microbiology and immunology.

[15]  J. Koropatnick,et al.  Extensive loss of human DNA accompanies loss of antibody production in heteromyeloma hybridoma cells. , 1988, Molecular biology & medicine.

[16]  G. Köhler,et al.  A better cell line for making hybridomas secreting specific antibodies , 1978, Nature.

[17]  J. F. Harris,et al.  A quantitative stability analysis of human monoclonal antibody production by heteromyeloma hybridomas, using an immunofluorescent technique. , 1985, Journal of immunological methods.

[18]  T. Hirano,et al.  Interleukin 6 induces secretion of IgG1 by coordinated transcriptional activation and differential mRNA accumulation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Scheidegger,et al.  Production of monoclonal antibodies: strategy and tactics. , 1980, Journal of immunological methods.

[20]  R. Lemieux,et al.  Increased proportion of B cell hybridomas secreting monoclonal antibodies of desired specificity in cultures containing macrophage-derived hybridoma growth factor (IL-6). , 1989, Journal of immunological methods.

[21]  D. French,et al.  The production of more useful monoclonal antibodies I. Modifications of the basic technology. , 1986, Immunology today.

[22]  B. Reiss,et al.  Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5. , 1982, Gene.

[23]  T. Hawley,et al.  Establishment of a novel factor-dependent myeloid cell line from primary cultures of mouse bone marrow. , 1991, Cytokine.

[24]  T. Hawley,et al.  Leukocytosis in mice following long-term reconstitution with genetically-modified bone marrow cells constitutively expressing interleukin 1 alpha or interleukin 6. , 1991, Leukemia research.

[25]  T. Taniguchi,et al.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin , 1986, Nature.

[26]  J. Snick,et al.  Interleukin-6: an overview. , 1990, Annual review of immunology.

[27]  J. Koropatnick,et al.  Spontaneous and radiation-induced genetic instability of heteromyeloma hybridoma cells. , 1990, Molecular biology & medicine.

[28]  D. Margulies,et al.  A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells , 1977, Somatic cell genetics.

[29]  A. D. de Blas,et al.  Estimation of the number of monoclonal hybridomas in a cell fusion experiment. Effect of post-fusion cell dilution on hybridoma survival. , 1981, Journal of immunological methods.

[30]  J. Renauld,et al.  cDNA cloning of murine interleukin‐HP1: homology with human interleukin 6 , 1988, European journal of immunology.

[31]  C. Milstein,et al.  A single-step procedure for cloning and selection of antibody-secreting hybridomas. , 1990, Journal of immunological methods.